Direct-to-consumer advertising for commercial genetic testing is on the rise and may

[News]

Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.

More... (http://www.news-medical.net/?id=33077)